Go to content

Publications

484 publications

Enter search criteria
Fill in keyword(s) to narrow your search.
Period
You can select a specific type of a publication you are looking for, such as press releases or speeches
Sort by:

  1. Febuxostat (Adenuric) for the treatment of chronic hyperuricaemia

    In conclusion, febuxostat can be said to have an equal value in comparison to allopurinol in the treatment of adult patients with ...

    Report | 27-10-2014

  2. Simeprevir (Olysio) for the indication chronic hepatitis C

    The therapeutic value of simeprevir in combination with pegIFN and ribavirin for the treatment of chronic hepatitis C genotype 1 ...

    Report | 22-09-2014

  3. Mannitol (Bronchitol) for the indication 'adult patients with cystic fibrosis

    The WAR has approved a pharmacotherapeutic report for the medicine mannitol (Bronchitol) capsules with dry powder for inhalation. ...

    Report | 28-07-2014

  4. Dolutegravir (Tivicay) for the indication infection with HIV-1

    The WAR has approved a pharmacotherapeutic report for the medicine dolutegravir (Tivicay). In determining its therapeutic value, ...

    Report | 28-07-2014

  5. Dike-Reeve of the health care polder

    Publication | 30-06-2014

  6. Sofosbuvir (Sovaldi) for the indication chronic hepatitis C in adult patients

    Sofosbuvir for the treatment of chronic hepatitis C in adult patients has added therapeutical value in comparison to relevant ...

    Report | 14-04-2014

  7. Macitentan (Opsumit) for the indication pulmonary arterial hypertension WHO class II to III

    The WAR has approved a pharmacotherapeutic report for the medicine macitentan (Opsumit®; an endothelin-1-receptor antagonist). In ...

    Report | 24-03-2014

  8. Canagliflozin (Invokana) for the treatment of adults with 'type 2 diabetes mellitus'

    The WAR has approved a pharmacotherapeutic report for the medicine canagliflozin (Invokana) in film-coated tablets with 100 ...

    Report | 24-03-2014

  9. Delta-9-tetrahydrocannabinol and cannabidiol (Sativex) with patients with moderate to severe spasticity due to multiple sclerosis

    The WAR has approved a pharmacotherapeutic report for the medicine delta-9-tetrahydrocannabinol and cannabidiol (Sativex) spray ...

    Report | 24-02-2014

  10. Herpes zoster vaccine (Zostavax) for the prevention of herpes zoster and herpes zoster-related post-herpetic neuralgia

    The WAR reached the follow conclusions: Zostavax has an added therapeutic value in comparison with placebo for the prevention of ...

    Report | 24-02-2014

Go to